Mary Allen

Also affiliated with University of Colorado Boulder, University of Colorado System, National Institute of Allergy and Infectious Diseases

Immunology and MicrobiologyMedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Data quality in an HIV vaccine efficacy clinical trial in South Africa: through natural disasters and with discipline

BMC Medical Research Methodology(2023)10.1186/s12874-023-01967-9

Top 100%

0DataRank

Top 100%0 citations

Mookho Malahleha, Shelly Ramirez, William Brumskine, Kennedy Otwombe, Zoe Moodie +2 more

Papers

Driven by 25 papers — median percentile 0. Top paper: “Safety and immune responses after a 12-month booster in healthy HIV-uninfected adults in HVTN 100 in South Africa: A randomized double-blind placebo-controlled trial of ALVAC-HIV (vCP2438) and bivalent subtype C gp120/MF59 vaccines”.

Safety and immune responses after a 12-month booster in healthy HIV-uninfected adults in HVTN 100 in South Africa: A randomized double-blind placebo-controlled trial of ALVAC-HIV (vCP2438) and bivalent subtype C gp120/MF59 vaccines

PLoS Medicine(2020)10.1371/journal.pmed.1003038

N/A

1.2DataRank · unranked

48 citations

Zoe Moodie, Kristen W. Cohen, Nicole Grunenberg, Linda‐Gail Bekker, Mary Allen +26 more

Analysis of the HIV Vaccine Trials Network 702 Phase 2b–3 HIV-1 Vaccine Trial in South Africa Assessing RV144 Antibody and T-Cell Correlates of HIV-1 Acquisition Risk

The Journal of Infectious Diseases(2022)10.1093/infdis/jiac260

N/A

1.1DataRank · unranked

50 citations

One Dintwe, Sheetal Sawant, Doug Grove, Yunda Huang, Holly Janes +43 more

Efficacy of a bivalent (D614 + B.1.351) SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant in adults: a phase 3, parallel, randomised, modified double-blind, placebo-controlled trial

The Lancet Respiratory Medicine(2023)10.1016/s2213-2600(23)00263-1

N/A

0.750DataRank · unranked

24 citations

Nadine Rouphael, Stephen R. Walsh, Aiying Chen, Nicole Grunenberg, Mary Allen +95 more

Safety and immunogenicity of a polyvalent DNA–protein HIV vaccine with matched Env immunogens delivered as a prime–boost regimen or coadministered in HIV-uninfected adults in the USA (HVTN 124): a phase 1, placebo-controlled, double-blind randomised controlled trial

The Lancet HIV(2024)10.1016/s2352-3018(24)00036-5

N/A

0.530DataRank · unranked

10 citations

Shuying S. Li, Nicole Grunenberg, Edgar T. Overton, Samuel T. Robinson, Hua Zheng +20 more

Macrophages derived from human induced pluripotent stem cells (iPSCs) serve as a high-fidelity cellular model for investigating HIV-1, dengue, and influenza viruses

Journal of Virology(2024)10.1128/jvi.01563-23

N/A

0.419DataRank · unranked

12 citations

Arturo Barbachano-Guerrero, Laurence M. Fairchild, Teisha J. Rowland, Robin D. Dowell, Mary Allen +3 more

Cellular and humoral responses to an HIV DNA prime by electroporation boosted with recombinant vesicular stomatitis virus expressing HIV subtype C Env in a randomized controlled clinical trial

Vaccine(2023)10.1016/j.vaccine.2023.03.015

N/A

0.405DataRank · unranked

8 citations

Benigno Rodríguez, Shuying Sue Li, Mary Allen, Ian Frank, Erika Rudnicki +17 more

Cellular zinc status alters chromatin accessibility and binding of p53 to DNA

Life Science Alliance(2024)10.26508/lsa.202402638

N/A

0.387DataRank · unranked

10 citations

Leah J. Damon, Lynn Sanford, Samuel E. Holtzen, Taylor Jones, Mary Allen +3 more

Focusing HIV-1 Gag T cell responses to highly conserved regions by DNA vaccination in HVTN 119

JCI Insight(2024)10.1172/jci.insight.180819

N/A

0.356DataRank · unranked

8 citations

Barbara K. Felber, James I. Mullins, Hyman Scott, Mary Allen, Stephen C. De Rosa +14 more

HIV Diagnostics and Vaccines: It Takes Two to Tango

The Journal of Infectious Diseases(2024)10.1093/infdis/jiae113

N/A

0.269DataRank · unranked

5 citations

Valérie Oriol-Mathieu, John Hural, L. Hattingh, Ferdinard Adungo, Ole Lagatie +15 more

LIET model: capturing the kinetics of RNA polymerase from loading to termination

Nucleic Acids Research(2025)10.1093/nar/gkaf246

N/A

0.241DataRank · unranked

4 citations

Georgia E F Barone, Hope A. Townsend, Rutendo F. Sigauke, Mary Allen, Robin D. Dowell +1 more

TF Profiler: a transcription factor inference method that broadly measures transcription factor activity and identifies mechanistically distinct networks

Genome biology(2025)10.1186/s13059-025-03545-2

N/A

0.241DataRank · unranked

4 citations

Rutendo F. Sigauke, Lynn Sanford, Dylan J. Taatjes, Mary Allen, Robin D. Dowell +1 more

Risk Factors Associated with HIV Acquisition in Males Participating in HIV Vaccine Efficacy Trials in South Africa

AIDS and Behavior(2023)10.1007/s10461-023-04025-z

N/A

0.208DataRank · unranked

3 citations

Fatima Laher, Athmanundh Dilraj, Philip Smith, Glenda Gray, Doug Grove +16 more

Mediator kinase inhibition suppresses hyperactive interferon signaling in Down syndrome

eLife(2024)10.7554/elife.100197

N/A

0.165DataRank · unranked

2 citations

Lynn Sanford, Samuel S. Hunter, Kayla Molison, Benjamin Erickson, Meaghan CS Courvan +9 more

Safety and immunogenicity after a 30-month boost of a subtype C ALVAC-HIV (vCP2438) vaccine prime plus bivalent subtype C gp120/MF59 vaccine boost (HVTN 100): A phase 1–2 randomized double-blind placebo-controlled trial

PLOS Global Public Health(2024)10.1371/journal.pgph.0003319

N/A

0.108DataRank · unranked

1 citations

Fatima Laher, Linda‐Gail Bekker, Kelly E. Seaton, Mary Allen, Stephen De Rosa +27 more

Benign ethnic neutropenia in a South African population, and its association with HIV acquisition and adverse event reporting in an HIV vaccine clinical trial

PLoS ONE(2021)10.1371/journal.pone.0241708

N/A

0DataRank · unranked

10 citations

Kennedy Otwombe, Koleka Mlisana, Maphoshane Nchabeleng, Mary Allen, James G. Kublin +6 more

Meta-analysis of HIV-1 vaccine elicited mucosal antibodies in humans

npj Vaccines(2021)10.1038/s41541-021-00305-8

N/A

0DataRank · unranked

15 citations

Aaron Deal, Xue Han, Shuying S. Li, Ashley Clayton, Jack Heptinstall +25 more

A retrospective analysis of incident pregnancy in Phase 1 and 2a HIV-1 vaccine study participants does not support concern for adverse pregnancy or birth outcomes

Research Square(2020)10.21203/rs.3.rs-23939/v1

N/A

0DataRank · unranked

0 citations

Chenchen Yu, Margaret Brewinski Isaacs, Mary Allen, Jessica Andriesen, Stephen R. Walsh +1 more

Long-term mucosal T cell activation and homing phenotypes in recipients of an Ad5-vectored HIV vaccine

Vaccine(2020)10.1016/j.vaccine.2020.06.043

N/A

0DataRank · unranked

4 citations

Jason Shao, Gabriela Diaz, Paul T. Edlefsen, Richard M. Novak, Kenneth H. Mayer +9 more

Antibody and cellular responses to HIV vaccine regimens with DNA plasmid as compared with ALVAC priming: An analysis of two randomized controlled trials

PLoS Medicine(2020)10.1371/journal.pmed.1003117

N/A

0DataRank · unranked

14 citations

Stephen R. Walsh, Fatima Laher, Lucas Maganga, Michael E. Herce, Sarita Naidoo +28 more

Single nucleus RNA-sequencing reveals transcriptional synchrony across different relationships

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.03.27.587112

N/A

0DataRank · unranked

6 citations

Julie M. Sadino, Allison C. Fultz, Michael A. Kelberman, Robin D. Dowell, Mary Allen +2 more

HIV-1 Vaccine Sequences Impact V1V2 Antibody Responses: A Comparison of Two Poxvirus Prime gp120 Boost Vaccine Regimens

Scientific Reports(2020)10.1038/s41598-020-57491-z

N/A

0DataRank · unranked

24 citations

Fatima Laher, Zoe Moodie, Arthur S. McMillan, Rachel L. Spreng, Peter B. Gilbert +15 more

A retrospective analysis of incident pregnancy in phase 1 and 2a HIV-1 vaccine study participants does not support concern for adverse pregnancy or birth outcomes

BMC Infectious Diseases(2021)10.1186/s12879-021-06431-x

N/A

0DataRank · unranked

2 citations

Chenchen Yu, Margaret Brewinski Isaacs, Mary Allen, Jessica Andriesen, Stephen R. Walsh +1 more

Use of Varied Screening Risk Criteria and HIV Incidence in Phase 1 and 2 HIV Vaccine Trials in South Africa

AIDS and Behavior(2022)10.1007/s10461-022-03867-3

N/A

0DataRank · unranked

1 citations

Kennedy Otwombe, Ofentse Mokwena, Linda‐Gail Bekker, Mary Allen, Fatima Laher

Mediator kinase inhibition suppresses hyperactive interferon signaling in Down syndrome

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.07.05.547813

N/A

0DataRank · unranked

1 citations

Lynn Sanford, Samuel S. Hunter, Kayla Molison, Benjamin Erickson, Meaghan CS Courvan +9 more

Data quality in an HIV vaccine efficacy clinical trial in South Africa: through natural disasters and with discipline

BMC Medical Research Methodology(2023)10.1186/s12874-023-01967-9

Top 100%

0DataRank

Top 100%0 citations

Mookho Malahleha, Shelly Ramirez, William Brumskine, Kennedy Otwombe, Zoe Moodie +2 more

Mary Allen

Indexed papers

Top data-sharing exemplar

Papers